Physiological Finding in Management of COVID 19 Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: physiological parameters.
- Who it may be relevant to
- Registry conditions: COVID-19 (Coronavirus Disease 2019). Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Taiwan
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Combined Usage of Clinical Physiological Finding in Management of COVID 19 Patients
Overview
This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.
Detailed description
This study utilizes physiological indicators of COVID-19 patients, such as blood pressure, heart rate, respiratory rate, and level of consciousness, to develop Shock Index (SI), Mordified Shock Index (MSI), Age Shock Index (Age SI), Age Mordified Shock Index (Age MSI), and Respiratory Adjusted Shock Index (RASI), as well as other physiological indicators, as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. For patients with mild to severe illness, and in response to the shortage of manpower during a large influx of emergency patients, this study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.
Interventions
- Other physiological parameters
systolic blood pressure, diastolic blood pressure , heart rate, respiratory rate , GCS
Primary outcome measures
- Shock index(SI) in the management of COVID -19 [Time frame: 2022 May to 2027 March]
- Mordified shock index(MSI) in the management of COVID -19 [Time frame: 2022 May to 2027 March]
- Age shock index(Age SI) in the management of COVID -19 [Time frame: 2022 May to 2027 March]
- Respiratory adjusted shock index (RASI) in the management of COVID-19 [Time frame: 2022 may to 2027 March]
Eligibility criteria
Inclusion criteria
- Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027
Exclusion criteria
- Excluding patients with incomplete clinical data or missing information in their medical records.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-control
Study locations
Taiwan · 2 centers
- St. Martin De Porres Hospital — Chiayi City
- St. Martin De Porres Hospital — Tainan
Identifiers
NCT: NCT07504341 · 26B-005 · 26B-005